NCT00002534View on ClinicalTrials.gov

Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second Remission

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 1993

Primary Completion Date

April 30, 2003

Study Completion Date

April 30, 2003

Conditions
Leukemia
Interventions
BIOLOGICAL

anti-thymocyte globulin

DRUG

cyclophosphamide

DRUG

cytarabine

DRUG

methylprednisolone

DRUG

thiotepa

PROCEDURE

allogeneic bone marrow transplantation

PROCEDURE

in vitro-treated bone marrow transplantation

RADIATION

low-LET electron therapy

RADIATION

low-LET photon therapy

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00002534 - Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second Remission | Biotech Hunter | Biotech Hunter